Quoin Pharmaceuticals Overview
- Year Founded
-
2018
- Status
-
Public
- Employees
-
11
- Stock Symbol
-
QNRX
- Investments
-
2
- Share Price
-
$3.59
- (As of Friday Closing)
Quoin Pharmaceuticals General Information
Description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Contact Information
Website
www.quoinpharma.comCorporate Office
- 42127 Pleasant Forest Court
- Ashburn, VA 20148-7349
- United States
Corporate Office
- 42127 Pleasant Forest Court
- Ashburn, VA 20148-7349
- United States
Quoin Pharmaceuticals Timeline
Quoin Pharmaceuticals Stock Performance
As of 13-Nov-2026, Quoin Pharmaceuticals’s stock price is $3.59. Its current market cap is $17.8M with 4.8M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.59 | $3.75 | $3.25 - $23.50 | $17.8M | 4.8M | 535K | -$6.00 |
Quoin Pharmaceuticals Financials Summary
As of 30-Sep-2026, Quoin Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 11,107 | 6,694 | (4,979) | (9,139) |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (20,032) | (16,187) | (9,421) | (9,277) |
| Net Income | (19,588) | (15,805) | (8,962) | (8,687) |
| Total Assets | 34,747 | 20,391 | 15,709 | 12,169 |
| Total Debt | 0 | 0 | 0 | 0 |
Quoin Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Quoin Pharmaceuticals Comparisons
Industry
Financing
Details
Quoin Pharmaceuticals Competitors (3)
One of Quoin Pharmaceuticals’s 3 competitors is Azitra, a Formerly VC-backed company based in Branford, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Azitra | Formerly VC-backed | Branford, CT | ||||
| PellePharm | Venture Capital-Backed | Palo Alto, CA | ||||
| Krystal Biotech | Formerly VC-backed | Pittsburgh, PA |
Quoin Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Quoin Pharmaceuticals Patents
Quoin Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026188023-A1 | Composition comprising a serine protease inhibitor for use in the treatment of particular skin disorders, such as netherton syndrome | Pending | 05-Mar-2025 | ||
| WO-2026183469-A1 | Treatment for particular skin disorders with rapamycin | Pending | 27-Feb-2025 | ||
| WO-2026064360-A1 | Combination of serine protease inhibitor and retinoid for treatment of particular skin disorders | Pending | 19-Sep-2024 | ||
| AU-2024212280-A1 | Combination treatment for netherton syndrome | Pending | 25-Jan-2023 | ||
| EP-4654947-A1 | Combination treatment for netherton syndrome | Pending | 25-Jan-2023 | A61K31/401 |
Quoin Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Quoin Pharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Quoin Pharmaceuticals Acquisitions (2)
Quoin Pharmaceuticals’s most recent deal was a Merger/Acquisition with Cellect Biotechnology for . The deal was made on 28-Oct-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Cellect Biotechnology | 28-Oct-2021 | Merger/Acquisition | Drug Discovery | ||
| Skinvisible Pharmaceuticals | 22-Oct-2019 | Merger/Acquisition | Other Devices and Supplies |
Quoin Pharmaceuticals Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Skinvisible Pharmaceuticals | Las Vegas, NV | 1998 |
Quoin Pharmaceuticals FAQs
-
When was Quoin Pharmaceuticals founded?
Quoin Pharmaceuticals was founded in 2018.
-
Where is Quoin Pharmaceuticals headquartered?
Quoin Pharmaceuticals is headquartered in Ashburn, VA.
-
What is the size of Quoin Pharmaceuticals?
Quoin Pharmaceuticals has 11 total employees.
-
What industry is Quoin Pharmaceuticals in?
Quoin Pharmaceuticals’s primary industry is Biotechnology.
-
Is Quoin Pharmaceuticals a private or public company?
Quoin Pharmaceuticals is a Public company.
-
What is Quoin Pharmaceuticals’s stock symbol?
The ticker symbol for Quoin Pharmaceuticals is QNRX.
-
What is the current stock price of Quoin Pharmaceuticals?
As of 13-Nov-2026 the stock price of Quoin Pharmaceuticals is $3.59.
-
What is the current market cap of Quoin Pharmaceuticals?
The current market capitalization of Quoin Pharmaceuticals is $17.8M.
-
Who are Quoin Pharmaceuticals’s competitors?
Azitra, PellePharm, and Krystal Biotech are competitors of Quoin Pharmaceuticals.
-
What is Quoin Pharmaceuticals’s annual earnings per share (EPS)?
Quoin Pharmaceuticals’s EPS for 12 months was -$6.00.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
